profit from every $100 of sales.
$0$100
Hyperion DeFi
$2.58-5.15% today
-48.1% in 1 year
1-year low $2.341-year high $5.01
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2023 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Hyperion DeFi sold, what it kept, and what it did with the cash.
Sales went from $0 in 2022 to $813,455 in 2025, with -$45.3 million of profit last year.
SalesProfit
Hyperion DeFi vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Hyperion DeFi | No profit yet | ||
 Boston Scientific | 22.2× · Fair price | ||
 Koninklijke Philips | 30.1× · Expensive | ||
 Steris | 32.8× · Expensive | ||
 Zimmer Biomet Holdings | 27.7× · Fair price |
AI analysis
An AI analyst reads Hyperion DeFi's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 0 | 0 | 1 | |
| 0 | -0 | -4 | 1 | |
| -27 | -25 | -38 | -19 | |
| -26 | -24 | -46 | -44 | |
| -28 | -27 | -50 | -45 | |
| -66.40 | -53.15 | -59.81 | -9.40 | |
| – | -322.6% | -6,749.5% | 62.7% | |
| – | -670,885.8% | -65,456.8% | -2,333.4% | |
| – | -719,859.9% | -86,888.6% | -5,570.6% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 31 | 29 | 4 | 52 |
| Cash | 23 | 15 | 2 | 6 |
| Total debt | 10 | 16 | 11 | 9 |
| Total liabilities | 14 | 20 | 17 | 11 |
| 17 | 9 | -13 | 41 | |
| 0 | 1 | 1 | 5 | |
| -76.9% | -78.4% | – | -69.7% | |
| -162.5% | -302.9% | 380.4% | -110.4% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -25 | -24 | -30 | -15 | |
| 1 | 4 | 0 | 72 | |
| -26 | -28 | -30 | -87 | |
| Dividends paid | – | – | 0 | 1 |
| – | – | – | – | |
| 4 | 2 | 2 | 6 |
Valuation
- –
- 1.8×
- –
- 0.6×
- 49.0×
- –
- –
- -217.7%
- -113.7%
- 0.0%
Profitability
- 62.7%
- -2,333.4%
- -5,570.6%
- -1,115.3%
- -38.3%
- 467.5%
- -130.0%
- -87.5%
- -38.7%
- 234.9%
Growth
- +1,365.6%
- –
- +51.2%
- –
- +97.4%
Financial health
- –
- 0.21
- 16.4%
- -12.2×
- 2.68
- 2.68
- 0.02
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 13%of 946
What analysts expect
- Average price target
- $5.88
- Range
- $4.00 – $7.75
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 14, 2026 | 0.26 | 1.32 | −80.3% |
| Mar 26, 2026 | -7.76 | -1.57 | −394.3% |
| Nov 13, 2025 | 0.05 | -7.20 | +100.7% |
| Aug 13, 2025 | -2.50 | – | – |
| May 19, 2025 | -1.59 | – | – |
News
TIER IV and Technical University of Munich Bring NVIDIA Hyperion to Level 4 Autonomous Driving in GermanyYahoo Finance · Oct 22, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/6Passes 1 of 6. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
31No pass
Benjamin Graham
75Pass
Philip Fisher
44No pass
Peter Lynch
–Not enough data
Joel Greenblatt
2No pass
Charlie Munger
45No pass
Terry Smith
37No pass
Questions about Hyperion DeFi
Is Hyperion DeFi a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 6 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Hyperion DeFi AI analysis
What does Hyperion DeFi do?
A U.S.-based firm pivoting from ophthalmic drug-delivery tech (Optejet) to becoming the first Nasdaq-listed U.S. company with a cryptocurrency treasury denominated in HYPE tokens from the Hyperliquid blockchain; also operates a validator (“Kinetiq × Hyperion”) and continues DeFi… It is in Medical - Devices.
Does Hyperion DeFi pay a dividend?
Yes. In 2025 it paid out $892,167 in dividends.
Is Hyperion DeFi stock halal?
Yes. Hyperion DeFi passes our halal screen: its business is permitted and its debt is 21% of its market value, under the 30% limit. How we check
How has Hyperion DeFi stock done over the past year?
Down 48.1% over the past twelve months, to $2.58. It traded between $2.34 and $5.01 and is 48.5% below its high.
Who are Hyperion DeFi's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with Hyperion DeFi's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.